Retina-Vitreous Associates Medical Group

Summary

Retina-Vitreous Associates Medical Group is a medical facility located in Beverly Hills, California. This center is recognized for care of Macular Degeneration, Age-Related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Retinal Disease and other specialties. Retina-Vitreous Associates Medical Group is involved with conducting 116 clinical trials across 51 conditions. There are 2 research doctors associated with this hospital, such as David Liao, MD, PhD and Beverly Hills Site PI.

Top PIs

Clinical Trials running at Retina-Vitreous Associates Medical Group

Age-Related Macular Degeneration

Macular Degeneration

Diabetic Retinopathy

Choroidal Neovascularization

Retinal Degeneration

Retinal Disease

None

Choroidal neovascularization

Wet AMD

Retinitis Pigmentosa

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

PDS Implant with Ranibizumab

for Age-Related Macular Degeneration

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.

Recruiting

2 awards

Phase 3

3 criteria

4D-150 + EYLEA

for Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting

2 awards

Phase 3

4 criteria